CD19-specific Chimeric Antigen Receptor [CS] - M000615883

Pharmacologic Code	M000615883
Pharmacologic Name	CD19-specific Chimeric Antigen Receptor
Pharmacologic Uses	CD19-directed genetically modified autologous T-cells
Pharmacologic Concept	Chemical Structure - [CS]
Pharmacologic Concept Description	This concept refers to the chemical structure and classification containing chemicals or other drug ingredients, organized into a chemical structure classification hierarchy.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class CD19-specific Chimeric Antigen Receptor [CS].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0078-0846	Kymriah	Non-Proprietary Name: Tisagenlecleucel	Injection, Suspension	Intravenous	Novartis Pharmaceuticals Corporation	ACTIVE
	0078-0958	Kymriah	Non-Proprietary Name: Tisagenlecleucel	Injection, Suspension	Intravenous	Novartis Pharmaceuticals Corporation	ACTIVE
	71287-119	Yescarta	Non-Proprietary Name: Axicabtagene Ciloleucel	Suspension	Intravenous	Kite Pharma, Inc.	ACTIVE